Skip to main content

Neil Osheroff Archives

Novel insights to antibiotic targets

Sep. 29, 2017—New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.

Read more


School of Medicine’s newest teaching award honors Nanney

Nov. 17, 2016—Vanderbilt University School of Medicine (VUSM) recently established the Academy for Excellence in Education Lillian B. Nanney Award for Outstanding Service to the VUSM/Vanderbilt University Medical Center (VUMC) Community of Educators.

Read more


Osheroff to direct Academy for Excellence in Education

Jul. 21, 2016—Neil Osheroff, Ph.D., has been named director of the Academy for Excellence in Education. He succeeds Lillian Nanney, Ph.D., who served as director since the Academy’s inception in 2007.

Read more


Slight chemical change may improve TB treatments: study

Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.

Read more


Anticancer olive compounds

Jul. 27, 2015—Compounds found in olives and olive oil have anticancer activity, which may contribute to the cancer preventive properties attributed to the Mediterranean diet.

Read more


Antibiotics with anticancer potential

Feb. 25, 2015—A series of experimental antibiotics may be a good starting point for developing new anticancer drugs.

Read more


Bacterial resistance breaks bridges

Mar. 14, 2013—Understanding how bacteria become resistant to quinolone antibiotics could guide strategies for developing new antibacterial drugs.

Read more


‘Detangler’ binds, bends and cuts DNA

Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

Read more